Open for inclusion

Potentially Resectable Metastatic Colorectal Cancer With Wild-type KRAS and BRAF: Alternating Chemotherapy Plus Cetuximab - A Randomised Phase II Trial

Cancer type: Colorectal cancer

Phase: II

Principal Investigator: Sørbye Halfdan

Country: NO

Keywords: Norway, Bergen

Status: Open for inclusion

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01867697